NIH-funded research R21 grant

Developing new lenses for cataract surgery that resist cell growth

Official title: Improving Outcomes in Cataract Surgery: Intraocular Lenses (IOLs) Resistant to Cell Growth

Funded at Texas Engineering Experiment Station · NIH-10783729 · Data updated 2026-11-12

This study is testing a new type of silicone lens for cataract surgery that aims to prevent common complications, like cloudy vision after surgery, so patients can have a better experience and possibly avoid extra surgeries.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionTexas Engineering Experiment Station
NIH-funded
Lab location1 site (College Station, United States)
Project startMarch 1, 2023
Project endFebruary 28, 2026
Funding year2024
Award (this year)$219,610
NIH project number5R21EY034598-02
Project IDNIH-10783729 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals scheduled for cataract surgery, particularly those from underrepresented or medically underserved populations.

Less likely to help

Patients who have already undergone cataract surgery and do not require lens replacement may not benefit from this research.

What this research studies

This research focuses on improving cataract surgery outcomes by creating intraocular lenses (IOLs) that resist the growth of lens epithelial cells, which can lead to complications after surgery. The study aims to develop a new type of silicone lens that minimizes the risk of posterior capsule opacification (PCO), a common issue affecting around 40% of patients. By integrating innovative surface-modifying additives into the lens design, the researchers hope to enhance the performance of IOLs while maintaining their mechanical properties. This could potentially reduce the need for additional surgeries to correct complications, improving overall patient experiences.

Why it matters

Potential benefit: If successful, this research could lead to safer cataract surgeries with fewer complications and reduced need for follow-up procedures.

How similar studies have gone: Previous research has shown promise in developing innovative IOL materials, suggesting that this approach could lead to significant advancements in cataract surgery outcomes.

Where this research is happening

  • Texas Engineering Experiment Station
    College Station, United States
    Active

Researchers

  • Principal investigator: Grunlan, Melissa — Texas Engineering Experiment Station
  • Study coordinator: Grunlan, Melissa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.